Mohammad Hossein Pourgholami
Mohammad Hossein Pourgholami
Professor of pharmacology, Tarbiat Modares University,
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
S Masoumi Moghaddam, A Amini, DL Morris, MH Pourgholami
Cancer and Metastasis Reviews 31, 143-162, 2012
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative …
RE Kast, JA Boockvar, A Brüning, F Cappello, WW Chang, B Cvek, ...
Oncotarget 4 (4), 502, 2013
The fruit essential oil of Pimpinella anisum exerts anticonvulsant effects in mice
MH Pourgholami, S Majzoob, M Javadi, M Kamalinejad, GHR Fanaee, ...
Journal of ethnopharmacology 66 (2), 211-215, 1999
Gene of the month: Interleukin 6 (IL-6)
P Ataie-Kachoie, MH Pourgholami, DR Richardson, DL Morris
Journal of clinical pathology 67 (11), 932-937, 2014
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole
MH Pourgholami, L Woon, R Almajd, J Akhter, P Bowery, DL Morris
Cancer letters 165 (1), 43-49, 2001
Involvement of urokinase‐type plasminogen activator system in cancer: An overview
AH Mekkawy, MH Pourgholami, DL Morris
Medicinal research reviews 34 (5), 918-956, 2014
Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer
P Ataie-Kachoie, MH Pourgholami, DL Morris
Cytokine & growth factor reviews 24 (2), 163-173, 2013
Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice
M Hossein Pourgholami, Z Yan Cai, Y Lu, L Wang, D Lawson Morris
Clinical Cancer Research 12 (6), 1928-1935, 2006
Solubilisation and cytotoxicity of albendazole encapsulated in cucurbit [n] uril
Y Zhao, DP Buck, DL Morris, MH Pourgholami, AI Day, JG Collins
Organic & Biomolecular Chemistry 6 (24), 4509-4515, 2008
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis
MH Pourgholami, J Akhter, L Wang, Y Lu, DL Morris
Cancer chemotherapy and pharmacology 55, 425-432, 2005
Evaluation of the anticonvulsant activity of the essential oil of Eugenia caryophyllata in male mice
MH Pourgholami, M Kamalinejad, M Javadi, S Majzoob, M Sayyah
Journal of ethnopharmacology 64 (2), 167-171, 1999
Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model
L Noorani, M Stenzel, R Liang, MH Pourgholami, DL Morris
Journal of nanobiotechnology 13, 1-12, 2015
Urokinase plasminogen activator system as a potential target for cancer therapy
AH Mekkawy, DL Morris, MH Pourgholami
Future Oncology 5 (9), 1487-1499, 2009
p70 Ribosomal protein S6 kinase (Rps6kb1): an update
F Bahrami-B, P Ataie-Kachoie, MH Pourgholami, DL Morris
Journal of clinical pathology 67 (12), 1019-1025, 2014
Diffuse malignant peritoneal mesothelioma–an update on treatment
P Mirarabshahii, K Pillai, TC Chua, MH Pourgholami, DL Morris
Cancer treatment reviews 38 (6), 605-612, 2012
In vitro and in vivo inhibition of liver cancer cells by 1, 25-dihydroxyvitamin D3
MH Pourgholami, J Akhter, Y Lu, DL Morris
Cancer letters 151 (1), 97-102, 2000
Effect of cross-linking on the performance of micelles as drug delivery carriers: a cell uptake study
Y Kim, MH Pourgholami, DL Morris, MH Stenzel
Biomacromolecules 13 (3), 814-825, 2012
Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole
SWL Chu, S Badar, DL Morris, MH Pourgholami
Anticancer research 29 (10), 3791-3796, 2009
Pilot Study of Albendazole in Patients with Advanced MalignancyEffect on Serum Tumor Markers/High Incidence of Neutropenia
DL Morris, JL Jourdan, MH Pourgholami
Oncology 61 (1), 42-46, 2001
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
MH Pourgholami, M Szwajcer, M Chin, W Liauw, J Seef, P Galettis, ...
Cancer chemotherapy and pharmacology 65, 597-605, 2010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20